Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insulet

284.07
-4.3300-1.50%
Volume:29.94K
Turnover:8.54M
Market Cap:19.99B
PE:51.20
High:286.25
Open:286.25
Low:283.49
Close:288.40
Loading ...

RBC Cuts Price Target on Insulet to $325 From $340, Keeps Outperform Rating

MT Newswires Live
·
15 Apr

Netflix, Crocs and 19 Other Stocks Make the 30-30 Club

GuruFocus.com
·
15 Apr

The Mag 7 Still Aren't Cheap. These Stocks Look More Attractive

Dow Jones
·
15 Apr

International Growth Drives GMED Stock Amid Fierce Competition

Zacks
·
15 Apr

Bruker Stock May Benefit Following Its Investment in Ridom GmbH

Zacks
·
14 Apr

Insulet Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
11 Apr

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

StockStory
·
11 Apr

Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength?

Zacks
·
10 Apr

Insulet Corp. Stock Rises Wednesday, Still Underperforms Market

Dow Jones
·
10 Apr

PODD Stock Benefits From the Launch of Omnipod 5 in Canada

Zacks
·
08 Apr

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

StockStory
·
08 Apr

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
08 Apr

Insulet (NasdaqGS:PODD) Launches Omnipod 5 In Canada As Shares Dip 7%

Simply Wall St.
·
08 Apr

Citigroup Adjusts Insulet Price Target to $315 From $355, Maintains Buy Rating

MT Newswires Live
·
07 Apr

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

CNW Group
·
07 Apr

Insulet Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
04 Apr

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Business Wire
·
03 Apr

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
01 Apr

Insulet Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
28 Mar

3 Reasons Investors Love Insulet (PODD)

StockStory
·
27 Mar